Reply from authors re: Hebert Alberto Vargas, Hedvig Hricak. Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. Eur Urol 2013;64:553-4: START: the beginning of a multidisciplinary effort to define the role of MRI-targeted Biopsy in the detection of clinically significant prostate cancer

Editorial

Caroline M Moore et al. Eur Urol. 2013 Oct.

. 2013 Oct;64(4):555-6.

doi: 10.1016/j.eururo.2013.07.002. Epub 2013 Jul 9.

No abstract available

Comment on

Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y; START Consortium. Moore CM, et al. Eur Urol. 2013 Oct;64(4):544-52. doi: 10.1016/j.eururo.2013.03.030. Epub 2013 Mar 20. Eur Urol. 2013. PMID: 23537686
Magnetic resonance imaging-targeted prostate biopsies: now is the time to START.
Vargas HA, Hricak H. Vargas HA, et al. Eur Urol. 2013 Oct;64(4):553-4. doi: 10.1016/j.eururo.2013.06.018. Epub 2013 Jun 19. Eur Urol. 2013. PMID: 23810194 No abstract available.